https://peptilogics.com/
Peptilogics
peptilogics
https://peptilogics.com/news/
News | Peptilogics
newspeptilogics
https://www.clinicaltrialsarena.com/news/peptilogics-periprosthetic-joint-infection-trial/
Peptilogics doses first subject in periprosthetic joint infection trial
Oct 7, 2022 - Peptilogics has dosed the first subject in the Phase Ib LOGIC-1 clinical trial of PLG0206 to treat periprosthetic joint infections.
joint infectionpeptilogicsdosesfirstsubject